Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 9, 2011

View Archived Issues

Cancer/testis family antigen described as independent predictor of prostate cancer recurrence

HDAd-mediated apolipoprotein A-I expression protects against atherosclerosis in vivo

Alere to make cash offer for Axis-Shield

Unigene and GSK enter further agreement for oral PTH analogue

FDA accepts NDA filing for BDP Nasal HFA

Novel lysophospholipid S1P1 receptor agonists presented by Sanofi

Botox receives positive opinion from Irish Medicines Board

Chelsea Therapeutics reaches target enrollment in phase II trial in fibromyalgia

French company presents novel agents for Parkinson's disease

Zafgen discloses new methionine aminopeptidase 2 inhibitors

Enrollment commences in phase I/II trial of OPB-31121

New hedgehog signaling inhibitors prepared at Selexagen

MGA-271 enters phase I trial in refractory cancer

Enrollment begins in first-in-human trial of SAR-125844

New androgen receptor antagonists claimed

Oasmia and Orion terminate agreement for Paclical in the Nordic region

ESMO and Thomson Reuters launch OncologyPRO portal

HUYA and SJTU School of Pharmacy King's Lab join forces

NeurogesX raises funds to support product development

SYGNIS completes recruitment in AXIS 2 study

Gilead to acquire clinical biologics manufacturing facility from Genentech

Phase III study of tivantinib/erlotinib combination begins in NSCLC

RNAi screen leads to identification of new target and agent for treatment of AML

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
UK Biobank delivers largest metabolomics dataset of 500K profiles
BioWorld Science
It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of 249 metabolites in the blood of its...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...